Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Oncology 1060

1060 - Improving the Synthesis of48V labeled [VO(acac)2] andIn Vitro andIn VivoValidation (ID 756)

Session Name
Preclinical Probes for Oncology (Poster Session)
Speakers
Authors
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Oncology
Presentation Number
1060

Previous Eposter
1552 - Metabotropic glutamate receptor subtype 5 function in fragile X syndrome (ID 883)

Next Eposters
1222 - Using comparative oncology approach to develop radioimmunotherapy for osteosarcoma (ID 96)
455 - Early peak equilibrium is superior to late pseudo-equilibrium for simplified quantification of 18F-FE-PE2I PET (ID 862)
1516 - Evaluation of PET Image Quality Using Non-Conventional Isotopes (ID 1146)
936a - Selective imaging of matrix metalloproteinase-13 to detect extracellular matrix remodelling in atherosclerotic lesions (ID 1350)
1053 - Development of a 89Zr radiolabeled anti-CD33 antibody for PET imaging of Acute Myeloid Leukemia (ID 736)
1633 - Discrepant Tc-99m PYP Planar grade and H/CL ratio: Which correlates better with diffuse tracer uptake on SPECT? (ID 517)
659 - Clinical Predictors of positive Tc-99m pyrophosphate scan in patients hospitalized for decompensated heart failure (ID 470)
385 - Extracting detector energy non-linearity correction factors from a single Lu-176 background spectrum using an artificial neural network. (ID 1130)
83 - NR2B (ID 150)
462 - First-in-Human study of [18F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals (ID 867)